MABVAX THERAPEUTICS HOLDINGS, INC. 4
4 · MABVAX THERAPEUTICS HOLDINGS, INC. · Filed Apr 4, 2017
Insider Transaction Report
Form 4
Cohen Kenneth M
Director
Transactions
- Exercise/Conversion
Common Stock
2017-04-02+1,543→ 7,557 total - Exercise/Conversion
Restricted Stock Unit
2017-04-02−1,543→ 1,543 total→ Common Stock (1,543 underlying)
Footnotes (3)
- [F1]Represents conversion of restricted stock units into common stock upon vesting of 1/3 of such units granted on April 2, 2015.
- [F2]Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer
- [F3]Restricted Stock Units vest over 3 years from April 2, 2015, 1/3 on each anniversary of the date of grant, subject to the Reporting Person's continued employment or service with the Issuer on each such vesting date.